United Kingdom Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
Description
United Kingdom Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
United Kingdom Diabetes Market will reach US$ 7.77 Billion in 2028 according to Renub Research. The United Kingdom has the worst diabetes condition in Europe, with the most overweight and obese adults, according to the WHO. As a result, United Kingdom, have more people than ever with diabetes. Diabetes is a chronic disease that happens either when the pancreas does not make sufficient insulin or when the body cannot beneficially use the insulin it produces.
United Kingdom Diabetes Industry to expand at a CAGR of 5.96% from 2022 to 2028
One of the biggest health challenges that the United Kingdom is facing nowadays is diabetes. Increasing health problems and complications will raise awareness of the risks, enhance self-management among people with diabetes, bring about wholesale lifestyle changes, and improve access to integrated diabetes care services. According to our research report, United Kingdom Diabetes Market was US$ 5.49 Billion in 2022.
1 in 14 people in the UK has diabetes, and the number of people diagnosed has doubled in the last 15 years.
The United Kingdom Diabetes Market is driven by the rise in unit sales and lessened by ASP depreciation. The critical driver of growth will be the upsurge in the diabetic population in the country and the increasing number of patients that require various diabetes care devices to manage their disease daily. There has been a rise in the diagnosis number of people living with diabetes in the U.K. According to the British Diabetes Association Data, diabetes patients increased by over 1.5 thousand in 2020, and the number will rise to 5.5 Million if the current trends continue and warned of a ""public health emergency"" by 2030.
More and more People will have Type 2 Diabetes in United Kingdom
The rate of newly diagnosed cases of Type 1 and Type 2 diabetes is seen to increase, mainly due to obesity, unhealthy diet, and physical inactivity. The rapidly increasing incidence and prevalence of diabetic patients and healthcare expenditure are indications of the increasing usage of diabetic care products. According to The British Diabetic Association, Diabetes prevalence 2021 data shows a rise in the number of with a diabetes in the UK. It is estimated that more than 13.6 Million are at increased risk of type 2 diabetes in the UK. At this rate, the number of diabetes people, including the undiagnosed diabetes population, is expected to rise to 5.5 Million by 2030.
Insulin Pen dominates the Market due to the High Number of Diabetes Patients
The U.K. diabetes market is classified into Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring (CGM) Devices, Insulin pens, and Insulin Pumps. The frequency of occurrence of diabetes patients and the introduction of new and improved technology in the healthcare sector are key elements fuelling growth in the U.K. market for insulin pen production and sales. The other driving forces are the increasing awareness related to needle stick injuries, diabetes monitoring and therapeutics for better disease management, and the rise in the adoption of attached medical devices.
The market share for insulin pumps will rise during the forecast period. The factors contributing to this growth are the surging cases of diabetes and awareness regarding the use of insulin pumps in the country. In addition, these pumps also provide distinct clinical benefits paired with new advanced features, like integrated CGM sensors, smartphone connectivity, etc., which fuel the demand for insulin pumps.
Government Initiatives will aid the Market
The National Service Framework (NSF) program improves services by setting national standards to improve the quality of service and tackle variations carefully. In addition, the Association of British HealthTech Industries (ABHI) 2019 launched a diabetes section, allowing diabetes technology companies to work together in one of its forums. The ABHI group is for any health technology company interested in diabetes care, from CGM and insulin pumps to apps.
Key Players:
The major players competing in the United Kingdom Market are B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickenson (B.D.), Novo Nordisk A/S, Ypsomed AG, Medtronic, Insulet Corporation, Abbott Laboratories, DarioHealth Corp., Dexcom Inc., Roche Diagnostic, and Tandem Diabetes Care.
In April 2022, Abbott, CamDiab, and Ypsomed announced that they are partnering to develop and commercialize an integrated automated insulin delivery (AID) system. The initial focus of the partnership will be on European countries. The connected, smart wearable solution is designed to monitor a person's glucose levels continuously and automatically adjust and deliver the right amount of insulin at the right time, removing the guesswork of insulin dosing.
In November 2021, ARKRAY, creator of the world's first HLPC HbA1c clinical analyzer, launched its brand in the U.K. and Europe. Its innovative diabetes testing systems are being marketed and supported directly to customers rather than through a distributor.
Renub Research report titled “United Kingdom Diabetes Market & Forecast, By Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Self-Monitoring Blood Glucose Device Analysis (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement) Insulin Pen Analysis – (User, Types – Disposable, Reusable and Smart Insulin Pen, Insulin Pen Needle Market, Reimbursement Policies), Insulin Pump Analysis - (Users, Market & Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP, Reimbursement Policies) Companies (B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nardisk, Ypsomed AG, Medtronic, InsuletCorporation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, Tandem Diabetes Care)” provides a complete analysis of United Kingdom Diabetes Industry.
Segments Market based on Devices
1. Continuous Glucose Monitoring (CGM)
2. Self-Monitoring Blood Glucose (SMBG)
3. Insulin Pen
4. Insulin Pump
United Kingdom Diabetes Sub-Segment Analysis
1. Continuous Glucose Monitoring (CGM) – United Kingdom Diabetes Market breakup from four viewpoints
1. Glucose Sensor Market & Forecast
2. CGM Transmitter Market & Forecast
3. CGM User
4. CGM Reimbursement
2. SMBG – United Kingdom Diabetes Market breakup from five viewpoints
1. Test Strips Market and Forecast
2. Lancet Market and Forecast
3. Meter Market and Forecast
4. Blood Glucose (SMBG) Users
5. Blood Glucose Devices Reimbursement
3. Insulin Pen Market – United Kingdom Diabetes Market breakup from six viewpoints
1. Disposable Insulin Pen
2. Reusable Insulin Pen
3. Smart Insulin Pen
4. Insulin Pen Needle Market
5. Insulin Pen Users
6. Reimbursement Policies
4. Insulin Pump Market – United Kingdom Diabetes Market breakup from four viewpoints
1. Insulin Pump Market
2. Insulin Pump Users
3. Insulin Pump Products
4. Reimbursement Policies
All the 13 Companies Studied in the Report have been Studied from 3 Points
• Company Overview
• Recent Developments
• Financial Insight
Company Analysis
1. B. Braun Melsungen AG
2. Eli Lilly and Company
3. Terumo Corporation
4. Becton, Dickinson (BD)
5. Novo Nardisk
6. Ypsomed AG
7. Medtronic
8. InsuletCororation
9. Abbott Laboratories
10. DarioHealth Crop
11. Dexcom, Inc
12. Roche Diagnostic
13. Tandem Diabetes Care
United Kingdom Diabetes Market will reach US$ 7.77 Billion in 2028 according to Renub Research. The United Kingdom has the worst diabetes condition in Europe, with the most overweight and obese adults, according to the WHO. As a result, United Kingdom, have more people than ever with diabetes. Diabetes is a chronic disease that happens either when the pancreas does not make sufficient insulin or when the body cannot beneficially use the insulin it produces.
United Kingdom Diabetes Industry to expand at a CAGR of 5.96% from 2022 to 2028
One of the biggest health challenges that the United Kingdom is facing nowadays is diabetes. Increasing health problems and complications will raise awareness of the risks, enhance self-management among people with diabetes, bring about wholesale lifestyle changes, and improve access to integrated diabetes care services. According to our research report, United Kingdom Diabetes Market was US$ 5.49 Billion in 2022.
1 in 14 people in the UK has diabetes, and the number of people diagnosed has doubled in the last 15 years.
The United Kingdom Diabetes Market is driven by the rise in unit sales and lessened by ASP depreciation. The critical driver of growth will be the upsurge in the diabetic population in the country and the increasing number of patients that require various diabetes care devices to manage their disease daily. There has been a rise in the diagnosis number of people living with diabetes in the U.K. According to the British Diabetes Association Data, diabetes patients increased by over 1.5 thousand in 2020, and the number will rise to 5.5 Million if the current trends continue and warned of a ""public health emergency"" by 2030.
More and more People will have Type 2 Diabetes in United Kingdom
The rate of newly diagnosed cases of Type 1 and Type 2 diabetes is seen to increase, mainly due to obesity, unhealthy diet, and physical inactivity. The rapidly increasing incidence and prevalence of diabetic patients and healthcare expenditure are indications of the increasing usage of diabetic care products. According to The British Diabetic Association, Diabetes prevalence 2021 data shows a rise in the number of with a diabetes in the UK. It is estimated that more than 13.6 Million are at increased risk of type 2 diabetes in the UK. At this rate, the number of diabetes people, including the undiagnosed diabetes population, is expected to rise to 5.5 Million by 2030.
Insulin Pen dominates the Market due to the High Number of Diabetes Patients
The U.K. diabetes market is classified into Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring (CGM) Devices, Insulin pens, and Insulin Pumps. The frequency of occurrence of diabetes patients and the introduction of new and improved technology in the healthcare sector are key elements fuelling growth in the U.K. market for insulin pen production and sales. The other driving forces are the increasing awareness related to needle stick injuries, diabetes monitoring and therapeutics for better disease management, and the rise in the adoption of attached medical devices.
The market share for insulin pumps will rise during the forecast period. The factors contributing to this growth are the surging cases of diabetes and awareness regarding the use of insulin pumps in the country. In addition, these pumps also provide distinct clinical benefits paired with new advanced features, like integrated CGM sensors, smartphone connectivity, etc., which fuel the demand for insulin pumps.
Government Initiatives will aid the Market
The National Service Framework (NSF) program improves services by setting national standards to improve the quality of service and tackle variations carefully. In addition, the Association of British HealthTech Industries (ABHI) 2019 launched a diabetes section, allowing diabetes technology companies to work together in one of its forums. The ABHI group is for any health technology company interested in diabetes care, from CGM and insulin pumps to apps.
Key Players:
The major players competing in the United Kingdom Market are B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickenson (B.D.), Novo Nordisk A/S, Ypsomed AG, Medtronic, Insulet Corporation, Abbott Laboratories, DarioHealth Corp., Dexcom Inc., Roche Diagnostic, and Tandem Diabetes Care.
In April 2022, Abbott, CamDiab, and Ypsomed announced that they are partnering to develop and commercialize an integrated automated insulin delivery (AID) system. The initial focus of the partnership will be on European countries. The connected, smart wearable solution is designed to monitor a person's glucose levels continuously and automatically adjust and deliver the right amount of insulin at the right time, removing the guesswork of insulin dosing.
In November 2021, ARKRAY, creator of the world's first HLPC HbA1c clinical analyzer, launched its brand in the U.K. and Europe. Its innovative diabetes testing systems are being marketed and supported directly to customers rather than through a distributor.
Renub Research report titled “United Kingdom Diabetes Market & Forecast, By Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Self-Monitoring Blood Glucose Device Analysis (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement) Insulin Pen Analysis – (User, Types – Disposable, Reusable and Smart Insulin Pen, Insulin Pen Needle Market, Reimbursement Policies), Insulin Pump Analysis - (Users, Market & Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP, Reimbursement Policies) Companies (B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nardisk, Ypsomed AG, Medtronic, InsuletCorporation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, Tandem Diabetes Care)” provides a complete analysis of United Kingdom Diabetes Industry.
Segments Market based on Devices
1. Continuous Glucose Monitoring (CGM)
2. Self-Monitoring Blood Glucose (SMBG)
3. Insulin Pen
4. Insulin Pump
United Kingdom Diabetes Sub-Segment Analysis
1. Continuous Glucose Monitoring (CGM) – United Kingdom Diabetes Market breakup from four viewpoints
1. Glucose Sensor Market & Forecast
2. CGM Transmitter Market & Forecast
3. CGM User
4. CGM Reimbursement
2. SMBG – United Kingdom Diabetes Market breakup from five viewpoints
1. Test Strips Market and Forecast
2. Lancet Market and Forecast
3. Meter Market and Forecast
4. Blood Glucose (SMBG) Users
5. Blood Glucose Devices Reimbursement
3. Insulin Pen Market – United Kingdom Diabetes Market breakup from six viewpoints
1. Disposable Insulin Pen
2. Reusable Insulin Pen
3. Smart Insulin Pen
4. Insulin Pen Needle Market
5. Insulin Pen Users
6. Reimbursement Policies
4. Insulin Pump Market – United Kingdom Diabetes Market breakup from four viewpoints
1. Insulin Pump Market
2. Insulin Pump Users
3. Insulin Pump Products
4. Reimbursement Policies
All the 13 Companies Studied in the Report have been Studied from 3 Points
• Company Overview
• Recent Developments
• Financial Insight
Company Analysis
1. B. Braun Melsungen AG
2. Eli Lilly and Company
3. Terumo Corporation
4. Becton, Dickinson (BD)
5. Novo Nardisk
6. Ypsomed AG
7. Medtronic
8. InsuletCororation
9. Abbott Laboratories
10. DarioHealth Crop
11. Dexcom, Inc
12. Roche Diagnostic
13. Tandem Diabetes Care
Table of Contents
190 Pages
- 1. Introduction
- 2. Research & Methodology
- 3. Executive Summary
- 4. Market Dynamics
- 4.1 Growth Drivers
- 4.2 Challenges
- 5. United Kingdom Diabetes Market
- 6. United Kingdom Diabetes Population
- 6.1 Type 1 Diabetes
- 6.2 Type 2 Diabetes
- 7. Market Share Analysis – United Kingdom Diabetic
- 7.1 By Types
- 8. Continuous Glucose Monitoring Market (CGM) – Market & Users
- 8.1 CGM Market by Components
- 8.1.1 Glucose Sensor Market
- 8.1.2 CGM Transmitter Market
- 8.2 CGM User
- 8.3 Reimbursement Policies of CGM Devices in United Kingdom
- 9. Blood Glucose Device (SMBG) – United Kingdom Market & Users
- 9.1 Market
- 9.1.1 Type 1 Diabetes Market
- 9.1.2 Type 2 Diabetes Market
- 9.2 Test Strips Market
- 9.2.1 Type 1 Diabetes
- 9.2.2 Type 2 Diabetes
- 9.3 Lancet Market
- 9.3.1 Type 1 Diabetes
- 9.3.2 Type 2 Diabetes
- 9.4 Meter Market and Forecast
- 9.4.1 Type 1 Diabetes
- 9.4.2 Type 2 Diabetes
- 9.5 Blood Glucose (SMBG) Users
- 9.5.1 Type 1 Diabetes
- 9.5.2 Type 2 Diabetes
- 9.6 Reimbursement Policies of Blood Glucose Devices in United Kingdom
- 10. Insulin Pen – United Kingdom Market & User
- 10.1 Insulin Pen Market
- 10.1.1 Disposable Insulin Pen Market
- 10.1.2 Reusable Insulin Pen Market
- 10.1.3 Smart Insulin Pen Market
- 10.2 Insulin Pen User
- 10.2.1 Disposable Insulin Pen User
- 10.2.2 Reusable Insulin Pen User
- 10.2.3 Smart Insulin Pen User
- 10.3 Insulin Pen Needle Market
- 10.4 Reimbursement Policies of Insulin Pen in United Kingdom
- 11. Insulin Pump - United Kingdom Market & Users
- 11.1 Insulin Pump Market
- 11.1.1 Type 1 Insulin Pump Market
- 11.1.2 Type 2 Insulin Pump Market
- 11.2 Insulin Pump User
- 11.2.1 Type 1 Insulin Pump User
- 11.2.2 Type 2 Insulin Pump User
- 11.3 Differentiation Points of Insulin Pump Products in United Kingdom
- 11.3.1 Animas Vibe
- 11.3.2 Medtronic 530G with Enlite
- 11.3.3 Insulet OmniPod
- 11.3.4 Tandem t: slim
- 11.3.5 Roche Accu-Chek Combo
- 11.4 Training Model for Patients & HCP – of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care
- 11.4.1 Medtronic
- 11.5 Insulet Corporation
- 11.5.1 Training Structure for New Patients - Insulet Corporation
- 11.6 Animas Corporation
- 11.6.1 Training Modules for New Patients
- 11.6.2 Training Modules for HCP (Health Care Professional)
- 11.7 Tandem Diabetes Care
- 11.8 Reimbursement Policies Insulin Pump
- 12. Insulin Pen – Company Analysis
- 12.1 B. Braun Melsungen AG
- 12.1.1 Overview
- 12.1.2 Recent Development
- 12.1.3 Revenue
- 12.2 Eli Lilly
- 12.2.1 Overview
- 12.2.2 Recent Development
- 12.2.3 Revenue
- 12.3 Terumo Corporation
- 12.3.1 Overview
- 12.3.2 Recent Development
- 12.3.3 Revenue
- 12.4 BD
- 12.4.1 Overview
- 12.4.2 Recent Development
- 12.4.3 Revenue
- 12.5 Novo Nordisk A/S
- 12.5.1 Overview
- 12.5.2 Recent Development
- 12.5.3 Revenue
- 12.6 Ypsomed AG
- 12.6.1 Overview
- 12.6.2 Recent Development
- 12.6.3 Revenue
- 13. Insulin Pump – Company Analysis
- 13.1 Medtronic
- 13.1.1 Overview
- 13.1.2 Recent Development
- 13.1.3 Revenue
- 13.2 Insulet Corporation
- 13.2.1 Overview
- 13.2.2 Insulin Pump – Product Details
- 13.2.3 Revenue
- 14. SMBG – Company Analysis
- 14.1 DarioHealth Corp
- 14.1.1 Overview
- 14.1.2 Recent Development
- 14.1.3 Revenue
- 14.2 Abbott Laboratories
- 14.2.1 Overview
- 14.2.2 Recent Development
- 14.2.3 Revenue
- 15. CGM – Company Analysis
- 15.1 Dexcom Inc
- 15.1.1 Overview
- 15.1.2 Recent Development
- 15.1.3 Revenue
- 15.2 Roche
- 15.2.1 Overview
- 15.2.2 Recent Development
- 15.2.3 Revenue
- 15.3 Tandem Diabetes Care
- 15.3.1 Overview
- 15.3.2 Recent Development
- 15.3.3 Revenue
- List of Figures:
- Figure-01: United Kingdom – Diabetes Market (Billion US$), 2017 – 2022
- Figure-02: United Kingdom – Forecast for Diabetes Market (Billion US$), 2023 – 2028
- Figure-03: United Kingdom – Type 1 Diabetes Population (Thousand), 2017 – 2022
- Figure-04: United Kingdom – Forecast for Type 1 Diabetes Population (Thousand), 2023 – 2028
- Figure-05: United Kingdom – Type 2 Diabetes Population (Thousand), 2017 – 2022
- Figure-06: United Kingdom – Forecast for Type 2 Diabetes Population (Thousand), 2023 – 2028
- Figure-07: United Kingdom – Glucose Sensor Market Market (Million US$), 2017 – 2023
- Figure-08: United Kingdom – Forecast for Glucose Sensor Market Market (Million US$), 2023 – 2028
- Figure-09: United Kingdom – CGM Transmitter Market Market (Million US$), 2017 – 2023
- Figure-10: United Kingdom – Forecast for CGM Transmitter Market Market (Million US$), 2023 – 2028
- Figure-11: United Kingdom – CGM User (Thousand), 2017 – 2023
- Figure-12: United Kingdom – Forecast for CGM User (Thousand),2023 – 2028
- Figure-13: United Kingdom – Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2023 – 2028
- Figure-14: United Kingdom – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2017 – 2023
- Figure-15: United Kingdom – Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2023 – 2028
- Figure-16: United Kingdom – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2017 – 2023
- Figure-17: United Kingdom – Test Strips Type 1 Diabetes Market (Million US$), 2023 – 2028
- Figure-18: United Kingdom – Forecast for Test Strips Type 1 Diabetes Market (Million US$), 2017 – 2023
- Figure-19: United Kingdom – Test Strips Type 2 Diabetes Market (Million US$), 2023 – 2028
- Figure-20: United Kingdom – Forecast for Test Strips Type 2 Diabetes Market (Million US$), 2017 – 2023
- Figure-21: United Kingdom – Lancet Type 1 Diabetes Market (Million US$), 2023 – 2028
- Figure-22: United Kingdom – Forecast for Lancet Type 1 Diabetes Market (Million US$), 2017 – 2023
- Figure-23: United Kingdom – Lancet Type 2 Diabetes Market (Million US$), 2023 – 2028
- Figure-24: United Kingdom – Forecast for Lancet Type 2 Diabetes Market (Million US$), 2017 – 2023
- Figure-25: United Kingdom – Meter Type 1 Diabetes Market (Million US$), 2023 – 2028
- Figure-26: United Kingdom – Forecast for Meter Type 1 Diabetes Market (Million US$), 2017 – 2023
- Figure-27: United Kingdom – Meter Type 2 Diabetes Market (Million US$), 2023 – 2028
- Figure-28: United Kingdom – Forecast for Meter Type 2 Diabetes Market (Million US$), 2017 – 2023
- Figure-29: United Kingdom – Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2017 – 2022
- Figure-30: United Kingdom – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2023 – 2028
- Figure-31: United Kingdom – Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2017 – 2022
- Figure-32: United Kingdom – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2023 – 2028
- Figure-33: United Kingdom – Disposable Insulin Pen Market (Million US$), 2017 – 2023
- Figure-34: United Kingdom – Forecast for Disposable Insulin Pen Market (Million US$), 2023 – 2028
- Figure-35: United Kingdom – Reusable Insulin Pen Market (Million US$), 2017 – 2023
- Figure-36: United Kingdom – Forecast for Reusable Insulin Pen Market (Million US$), 2023 – 2028
- Figure-37: United Kingdom – Smart Insulin Pen Market (Million US$), 2017 – 2023
- Figure-38: United Kingdom – Forecast for Smart Insulin Pen Market (Million US$), 2023 – 2028
- Figure-39: United Kingdom – Disposable Insulin Pen User (Thousand), 2017 – 2022
- Figure-40: United Kingdom – Forecast for Disposable Insulin Pen User (Thousand), 2023 – 2028
- Figure-41: United Kingdom – Reusable Insulin Pen User (Thousand), 2017 – 2022
- Figure-42: United Kingdom – Forecast for Reusable Insulin Pen User (Thousand), 2023 – 2028
- Figure-43: United Kingdom – Smart Insulin Pen User (Thousand), 2017 – 2022
- Figure-44: United Kingdom – Forecast for Smart Insulin Pen User (Thousand), 2023 – 2028
- Figure-45: United Kingdom – Insulin Pen Needle Market Market (Million US$), 2017 – 2023
- Figure-46: United Kingdom – Forecast for Pen Needle Market for Market (Million US$), 2023 – 2028
- Figure-47: United Kingdom – Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2017 – 2023
- Figure-48: United Kingdom – Forecast for Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2023 – 2028
- Figure-49: United Kingdom – Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2017 – 2023
- Figure-50: United Kingdom – Forecast for Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2023 – 2028
- Figure-51: United Kingdom – Insulin Pump Type 1 Users (Thousand), 2017 – 2022
- Figure-52: United Kingdom – Forecast for Insulin Pump Type 1 Users (Thousand), 2023 – 2028
- Figure-53: United Kingdom – Insulin Pump Type 2 Users (Thousand), 2017 – 2022
- Figure-54: United Kingdom – Forecast for Insulin Pump Type 2 Users (Thousand), 2023 – 2028
- Figure-55: B. Braun Melsungen AG – Global Revenue (Billion US$), 2017 – 2022
- Figure-56: B. Braun Melsungen AG – Forecast for Global Revenue (Billion US$), 2023 – 2028
- Figure-57: Eli Lilly – Global Revenue (Billion US$), 2017 – 2022
- Figure-58: Eli Lilly – Forecast for Global Revenue (Billion US$), 2023 – 2028
- Figure-59: Terumo Corporation – Global Revenue (Billion US$), 2017 – 2022
- Figure-60: Terumo Corporation – Forecast for Global Revenue (Billion US$), 2023 – 2028
- Figure-61: BD – Global Revenue (Billion US$), 2017 – 2022
- Figure-62: BD – Forecast for Global Revenue (Billion US$), 2023 – 2028
- Figure-63: Novo Nordisk A/S – Global Revenue (Billion US$), 2017 – 2022
- Figure-64: Novo Nordisk A/S – Forecast for Global Revenue (Billion US$), 2023 – 2028
- Figure-65: Ypsomed AG – Global Revenue (Billion US$), 2017 – 2022
- Figure-66: Ypsomed AG – Forecast for Global Revenue (Billion US$), 2023 – 2028
- Figure-67: Medtronic – Global Revenue (Billion US$), 2017 – 2022
- Figure-68: Medtronic – Forecast for Global Revenue (Billion US$), 2023 – 2028
- Figure-69: Insulet Corporation – Global Revenue (Billion US$), 2017 – 2022
- Figure-70: Insulet Corporation – Forecast for Global Revenue (Billion US$), 2023 – 2028
- Figure-71: DarioHealth Corp – Global Revenue (Billion US$), 2017 – 2022
- Figure-72: DarioHealth Corp – Forecast for Global Revenue (Billion US$), 2023 – 2028
- Figure-73: Abbott Laboratories – Global Revenue (Billion US$), 2017 – 2022
- Figure-74: Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2023 – 2028
- Figure-75: Dexcom Inc – Global Revenue (Billion US$), 2017 – 2022
- Figure-76: Dexcom Inc – Forecast for Global Revenue (Billion US$), 2023 – 2028
- Figure-77: Roche – Global Revenue (Billion US$), 2017 – 2022
- Figure-78: Roche – Forecast for Global Revenue (Billion US$), 2023 – 2028
- Figure-79: Tandem Diabetes Care – Global Revenue (Billion US$), 2017 – 2022
- Figure-80: Tandem Diabetes Care – Forecast for Global Revenue (Billion US$), 2023 – 2028
- List of Tables:
- Table-01: United Kingdom – Diabetes Market Share by Type (Percent), 2017 – 2022
- Table-02: United Kingdom – Forecast for Diabetes Market Share by Type (Percent), 2023 – 2028
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
